Takayasu's arteritis (TA) is a systemic vasculitis that affects mainly the aorta and its major branches. Despite being the third most frequent vasculitis in childhood, the occurrence of TA in the pediatric age group is scarce. We report three cases of TA in children, emphasizing signs and symptoms, angiographic alterations and therapeutics.
INTRODUCTION
Takayasu's arteritis (TA) is a systemic granulomatous vasculitis of large vessels that mainly affects the aorta and its large branches. It is the third most frequent vasculitis of childhood. 1 Most patients diagnosed are women in third decade of life; 1 however, the disease has been reported in children as young as seven months of age. 2 The diagnosis of TA is based on the EULAR/PRINTO/ PRES criteria, that comprises: angiographic abnormalities, alterations in peripheral arterial pulses, systolic blood pressure (BP) discrepancy in any limb, arterial hypertension, large artery bruits, and elevated acute phase reactant. 3 The treatment of TA requires the use of corticosteroids, which can be associated with immunosuppressive or biological agents. Some cases benefi t from surgical intervention. 1 Despite the increasing identifi cation of children and adolescents with TA, reports of disease in this population are still scarce among us. 4 Thus, we report three patients with TA diagnosed according to the established criteria 
CASE REPORT

Case 1
The 15-year-old female patient was admitted in October 2007 complaining of fatigue, headache and intermittent claudication of upper limbs for one year. Symptoms were attributed to chronic anemia. The physical examination revealed the following: impalpable peripheral pulses and inaudible blood pressure showed infl ammatory activity, and imaging studies suggested TA.
In December 2007, because of extensive arterial impairment and clinical severity, monthly pulse therapy with methylprednisolone (MTP) was initiated in association with pulse therapy with cyclophosphamide (CTX) and oral prednisone (1 mg/day), in addition to anti-hypertensive drugs. The patient did not respond to the immunosuppression instituted, which was changed to subcutaneous methotrexate (SC MTX) 25 mg/ week, associated with oral corticoid. Due to the persistence of symptoms and arterial hypertension 18 months after beginning therapy, six infusions of infl iximab (5 mg/kg/dose) were prescribed. After starting biologic therapy, the patient evolved with symptom remission, and oral corticoid could be progressively reduced. Systemic arterial hypertension (SAH), however, persisted despite the use of fi ve anti-hypertensive drugs. Monthly pulse therapy with MTP and oral prednisone (1 mg/kg/day) was prescribed in association with anti-hypertensive drugs. In November 2009, due to arterial hypertension of diffi cult control, the patient underwent percutaneous transluminal angioplasty with stent placement in the left renal artery and aneurysm embolization with fi ber coils. The images before and after the procedure are shown in Figure 1 . After the procedure, pulse therapy was suspended, and SC MTX (25 mg/ week) was associated, allowing for a gradual reduction in oral corticotherapy. The patient evolved with a partial reduction in BP and kept using four classes of anti-hypertensive drugs.
Case 3
Female patient who, at the age of 8 years, began complaining of daily headache and abdominal pain, being then diagnosed with abdominal migraine. At the age of 10 years, she was referred to the Rheumatology Service due to arterial hypertension and the echographic fi nding of ascending aortic aneurysm. On physical Table 1 lists the infl ammatory activity tests, at diagnosis and after treatment, and the patients' radiological fi ndings at diagnosis.
DISCUSSION
TA is rarely described in the pediatric age group, especially among us. In the international literature, a recent review article reported a total of 241 TA cases published in the pediatric age group. 5 So far, to our knowledge, 21 pediatric cases have been published in Brazil. [5] [6] [7] [8] [9] We report three patients with TA, corresponding to 14.2% of the national cases published.
Due to the lack of specifi city of the initial clinical manifestations, insidious evolution and need for a detailed cardiovascular physical examination, it is believed that many cases are not diagnosed or receive a late diagnosis. 10 All our three patients were initially diagnosed with pathologies different from TA, such as chronic anemia, CoAo, and abdominal migraine, after one, two, and fi ve years from symptom onset.
In childhood, headache is the most frequent initial nonspecifi c symptom of TA, occurring in 31% of cases. 1, 10 Our three patients had headache, emphasizing the inclusion of TA in the differential etiological diagnosis. Two patients reported fatigue, a common complaint in the literature, 1 which corroborates the need for giving attention to that complaint. One patient reported claudication of the upper limbs, which is highly specifi c for TA. 3 Abdominal pain occurs in 5% to 50% of the cases 10 and was reported in our younger patient. Arterial hypertension is the most common fi nding on physical examination of children and adolescents with TA (82.6%), and often suggests the diagnosis. 10 All patients were hypertensive at the diagnosis, which led to the referral of two of them. In literature, the prevalence of such fi ndings varies greatly, occurring in 5% to 58% of patients, probably due to the small number of cases published.
The tests of infl ammatory activity are elevated in most cases, 3, 10 similarly to our results. In our cases, this fi nding and their clinical features supported the request for imaging studies and helped to establish our patients' diagnosis.
The characteristic fi nding on angiography is the diffuse involvement of the aorta. The most commonly found lesion is stenosis (53%), followed by occlusion (21%), and aneurysm (10%). The most affected arteries are the renal arteries (73%). 10 Our cases are in accordance with those in literature: two patients had stenosis, occlusion, and aneurysm, and one patient had stenosis and diffuse occlusion of the aorta. All patients had impairment of the renal artery.
The treatment of TA consists of prescribing corticosteroids, which can be associated, initially or during the evolution, with either CTX or MTX in cases of progressive disease, or biologic agents in resistant cases. Surgical intervention may have good results in cases of severe renovascular hypertension. 1, 10 All patients received initial treatment with corticosteroids, and subsequent association of MTX. Only the patient of case 2 did not receive CTX, because she underwent the intravascular procedure. The patient of case 1 received infl iximab because of resistance to immunosuppressive drugs. All our patients had a good response to therapy and had their infl ammatory activity normalized, maintaining SAH despite the use of antihypertensive drugs.
The report of rare cases, such as the ones in this article, helps to improve the knowledge of pediatricians and rheumatologists about TA in childhood, allowing early diagnosis and better therapeutic results. Abdominal angiotomography: bilateral renal stenosis, aneurysm of the left renal artery, stenosis of the infrarenal abdominal aorta, aneurysm of the infrarenal abdominal aorta.
Abdominal angiotomography: aneurysm of the ascending aorta and right renal artery. Renal arteriography: aneurysm and partial occlusion of the right renal artery.
ESR: erythrocyte sedimentation rate; PCR: C-reactive protein.
